Publication of Supplement to Prospectus

ITV PLC

07 June 2024

 

RNS Number: 6585R
ITV PLC
7 June 2024

7 June 2024

ITV PLC

PUBLICATION OF SUPPLEMENT TO PROSPECTUS

ITV Plc (the "Company") today announces, regarding the Company's €3,000,000,000 Euro Medium Term Note Programme (the "Programme"), they have published a supplement (the "Supplement") to the base prospectus dated 28 March 2024 in respect of the Programme (the "Prospectus"). The Supplement has been approved by the Financial Conduct Authority and is available for viewing.

The Supplement should be read and construed in conjunction with the Prospectus.

To view the Supplement, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/6585R_1-2024-6-7.pdf

The Supplement will also be available for viewing at the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

Group Secretariat

ITV Plc

White City Place
201 Wood Lane
London
W12 7RU

[e-mail]

For general enquiries, please contact Investor Relations:

Pippa Foulds                           [phone]

Faye Dipnarine                         [phone]

LEI for ITV plc: ZLECI7ED2QMWFGYCXZ59

Website: www.itv.com; investor information: www.itvplc.com

DISCLAIMER - INTENDED ADDRESSEES

EU MiFID II professionals/ECPs only/No EEA PRIIPs KID

UK MiFIR professionals/ECPs only/No UK PRIIPs KID

Please note that the information contained in the Prospectus, as supplemented (the "Supplemented Prospectus") may be addressed to and/or targeted at persons who are residents of particular countries (as specified in the Supplemented Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Supplemented Prospectus is not addressed. Prior to relying on the information contained in the Supplemented Prospectus, you must ascertain from the Supplemented Prospectus whether or not you are part of the intended addressees of the information contained therein.

In particular, neither this announcement nor the Supplemented Prospectus shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The Notes have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or under the securities laws of any state or other jurisdiction of the United States, and the Notes may not be offered, sold, pledged, taken up, resold, transferred or delivered, directly or indirectly, in the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act ("Regulation S")) unless the Notes are registered under the Securities Act or an exemption from the registration requirements for the Securities Act is available. The Notes are being offered and sold only to non-U.S. persons outside the United States in reliance upon Regulation S. The Supplemented Prospectus may not be accessed from, or transmitted in or into, the United States.

Your right to access this service is conditional upon complying with the above requirements.

 

END